
CVS Health Corporation (CVS)
$
70.08
-1.10 (-1.57%)
Key metrics
Financial statements
Free cash flow per share
6.1472
Market cap
89.2 Billion
Price to sales ratio
0.2217
Debt to equity
1.2444
Current ratio
0.8424
Income quality
3.6150
Average inventory
19.1 Billion
ROE
0.0234
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.00 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $10,385,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $55,362,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $74.92 suitable for budget-conscious investors, while its high average trading volume of 8,648,750.00 indicates strong liquidity. With a large market capitalization of $89,156,476,800.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.
Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict CVS Health Corporation stock to fluctuate between $58.35 (low) and $85.15 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-27, CVS Health Corporation's market cap is $89,156,476,800, based on 1,272,210,000 outstanding shares.
Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.
CVS Health Corporation pays dividends. The current dividend yield is 3.80%, with a payout of $0.67 per share.
To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
CVS Health Corporation's last stock split was 2:1 on 2005-06-07.
Revenue: $402,067,000,000 | EPS: $1.40 | Growth: -61.75%.
Visit https://www.cvshealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

globenewswire.com
The plant-based wellness brand's best-selling mosquito repellent and itch relief patches hit shelves at more than 4,700 CVS stores across 48 states The plant-based wellness brand's best-selling mosquito repellent and itch relief patches hit shelves at more than 4,700 CVS stores across 48 states

zacks.com
CVS Health (CVS) concluded the recent trading session at $72.8, signifying a +2.12% move from its prior day's close.

zacks.com
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

businesswire.com
NEW YORK--(BUSINESS WIRE)--Bernstein Litowitz Berger & Grossmann LLP (BLB&G) announces the filing of a class action against leading pharmacy benefits manager CaremarkPCS Health, LLC along with its corporate parent, CVS Health Corporation. Plaintiff Roofers' Union Welfare Trust, which provides healthcare benefits for members of Local 11 Union of Roofers, Waterproofers and Allied Workers, brought this action to hold CaremarkPCS and CVS accountable for defrauding PBM customers. This class.

prnewswire.com
WOONSOCKET, R.I., March 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

zacks.com
In the most recent trading session, CVS Health (CVS) closed at $74.81, indicating a -1.36% shift from the previous trading day.

zacks.com
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

fool.com
These two healthcare leaders have businesses built to withstand economic downturns. Both have grown their dividends at a pretty good clip over the past decade.

seekingalpha.com
CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript

seekingalpha.com
CVS Health Corporation is rated a Buy, with a bullish outlook for 2026–2027 driven by margin recovery and undervalued valuation metrics. CVS trades at attractive forward P/S (~0.25x) and P/E (~13x), with potential for >50% share price upside if Medicare Advantage margins recover. 2026 guidance projects improved Medical Benefit Ratio, rising GAAP EPS ($6.04), and margin expansion across all divisions despite flat revenues.
See all news